170437 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interleukins [IL] IL-1
CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#2ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME
#3MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#4SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#5NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#6BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#7EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS
#8GASDERMIN E EXPRESSION IN HUMAN T CELLS AS A MARKER FOR PROINFLAMMATORY T CELL FUNCTIONS
#9METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DOSING REGIMENS
#10MONITORING INFLAMMATION STATUS
#11INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION
#12DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS BASED ON SALIVARY IL-1BETA AND MMP-9
#13COMPOSITION FOR TREATING SOLID MALIGNANT TUMOR, AND KIT FOR TREATING SOLID MALIGNANT TUMOR
#14RED BLOOD CELL-DERIVED MAGNETIC IMMUNO-PARTICLE AND USE THEREOF
#15TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#16VAGUS NERVE STIMULATION PRE-SCREENING TEST
#17ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES
#18DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING
#19MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#20URINARY TRACT INFECTION DIAGNOSTIC
#21TNF-ALPHA AND IL-1ALPHA POSITIVE COPD TREATMENT WITH ANTIBIOTICS
#22DIAGNOSIS AND TREATMENT OF PRIMARY GRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANT
#23METHOD FOR PREDICTING CAUSE-SPECIFIC THERAPEUTIC EFFECT OF SENSORINEURAL HEARING LOSS, AND DIAGNOSTIC KIT USED THEREFOR
#24DIAGNOSTICS OF GINGIVITIS
#25Biomarkers for Identifying Relapses in Multiple Sclerosis
#26HIGH DOSE NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) PRECURSOR REGIMENS FOR REDUCTION OF INFLAMMATION IN HUMAN PATIENTS WITH PREEXISTING INFLAMMATION
#27METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#28ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#29ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING ACUTE ANTIDEPRESSANT RESPONSE AND REMISSION IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#30Antibodies Against IL-1 Beta
#31GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC IL1B AND/OR IL1A
#32Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer
#33Biomarker of gingivitis diagnosis and treatment
#34SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#35MATERIALS AND METHODS FOR MONITORING INFLAMMATION
#36TREATMENT AND DIAGNOSIS OF CHRONIC INFLAMMATORY CONDITIONS IN THE LOWER URINARY TRACT
#37LATERAL FLOW DEVICE
#38USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#39Vagus nerve stimulation pre-screening test
#40BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#41Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#42NOVEL THERAPY
#43Classification of periodontitis patients
#44DIAGNOSIS AND TREATMENT OF IMMUNOTHERAPY-INDUCED NEUROTOXICITY
#45METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#46METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#47Treatment of Placental Chronic Histiocytic Intervillositis Using an Inhibitor of Interleukin-1
#48METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#49Biocompatible and bioabsorbable derivatized chitosan compositions
#50MODULATION OF SPLENOCYTES IN CELL THERAPY
#51Nucleic acids encoding antibodies against IL-1 beta
#52ASTROCYTE EXOSOME COMPLEMENT-BASED ASSAY FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE AND USES THEREOF
#53SOLUBLE HUMAN ST-2 ANTIBODIES AND ASSAYS
#54METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#55Biomarkers related to organ function
#56URINARY TRACT INFECTION DIAGNOSTIC
#57METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER
#58Antibody to human IL-1 beta
#59DIAGNOSTICS OF GINGIVITIS BASED ON SALIVARY IL-1BETA AND HGF
#60Methods for assessing treatment with a gastrointestinal implant
#61Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
#62METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#63Method for identifying a bacterial infection
#64System for detecting infection in synovial fluid
#65Vagus nerve stimulation pre-screening test
#66Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#67Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#68Nucleic acid encoding antibody to human IL-1 beta
#69Peptides for blocking IL1RAP protein-protein interaction and uses thereof for treatment of disease
#70ANTIBODIES AGAINST IL-1 BETA
#71Modulation of splenocytes in cell therapy
#72Biocompatible and bioabsorbable derivatized chitosan compositions
#73METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#74Human antibody specific for interleukin-1 alpha
#75Therapy
#76ANTI-INFLAMMATORY AGENTS
#77BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#78Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#79ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#80TREATMENT OF LYSOSOMAL DISORDERS (IL-1 ANTAGONISTS)
#81Human exhaled aerosol droplet biomarker system and method
#82Biocompatible and bioabsorbable derivatized chitosan compositions
#83Diagnosis of urothelial cancer
#84METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#85Method of inhibiting human IL-1 beta by administering an antibody to human IL-1 beta
#86Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#87Biomarkers associated with schizophrenia
#88Biocompatible and bioabsorbable derivatized chitosan compositions
#89METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#90Method for evaluating the harmful effects of UV on children's skin
#91METHOD FOR DIAGNOSING AN INFLAMMATORY CONDITION IN THE FEMALE GENITAL TRACT
#92Biomarkers for Tuberculosis
#93Biomarkers related to organ function
#94PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#95Antibodies against IL-1 beta
#96METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#97Suppression of cytokine release and cytokine storm
#98Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#99Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#100Methods of treating pain using protein solutions
#101Biomarker for psychiatric and neurological disorders
#102Methods for determining responsiveness to an anti-CD47 agent
#103DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#104Method for identifying a bacterial infection
#105Process for assessing risk of substance administration
#106Human antibody specific for interleukin-1alpha
#107Method and kit for cytokine analysis from a human whole blood sample
#108Soluble human ST-2 antibodies and assays
#109DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
#110ANTI-INFLAMMATORY AGENTS
#111Diagnosis and risk stratification of bladder cancer
#112TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#113VAGUS NERVE STIMULATION SCREENING TEST
#114Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
#115Biomarker of renal dysfunction
#116METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#117Methods For Determining Anti-TNF Therapeutic Response
#118Microfluidic device for generating neural cells to simulate post-stroke conditions
#119Biomarker of renal dysfunction
#120Human antibody specific for IL-1alpha
#121Methods and kits for diagnosing osteoarthritis and predicting progression
#122PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#123System for detecting infection in synovial fluid
#124MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS
#125Single Molecule Assays
#126Biomarkers for prediction, diagnosis, and monitoring of parkinson's disease
#127Biocompatible and bioabsorbable derivatized chitosan compositions
#128Dual variable domain immunoglobulins and uses thereof
#129IL-1 binding proteins
#130IL-1 binding proteins
#131IL-1 binding proteins
#132IL-1 binding proteins
#133Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α
#134Antibody to human IL-1 beta
#135IL-1 binding proteins
#136Human exhaled aerosol droplet biomarker system and method
#137Method for screening drugs for suppressing inflammasome activity
#138Methods of determining chondrocytes
#139Soluble human ST-2 antibodies and assays
#140Obesity Dependent Adipokine Biomarkers for Prostate Cancer
#141DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#142MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS
#143Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
#144Interleukin-1 Alpha Antibodies and Methods of Use
#145Urinary biomarkers for cancer diagnosis
#146BIOMARKERS
#147Methods and kits for diagnosing osteoarthritis and predicting progression
#148Dual variable domain immunoglobulins and uses thereof
#149Interleukin-1 Alpha Antibodies and Methods of Use
#150IL-1F5 polypeptides
#151Interleukin-1 alpha antibodies and methods of use
#152Interleukin-1α antibodies and methods of use
#153Interleukin-1 alpha antibodies and methods of use
#154Modulation of splenocytes in cell therapy
#155IL-1 binding proteins
#156Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#157Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
#158Soluble human ST-2 antibodies and assays
#159Methods For Improving Skin Quality
#160Methods For Improving Skin Quality
#161Methods For Improving Skin Quality
#162Methods For Improving Skin Quality
#163Methods For Improving Skin Quality
#164IL-1 binding proteins
#165Methods and apparatus for conducting multiple measurements on a sample
#166Diagnosis and/or prognosis of renal dysfunction
#167METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS
#168METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#169Biomarkers for chronic vascular dysfunction
#170SINGLE MOLECULE ASSAYS
#171Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients
#172Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#173Dual variable domain immunoglobulins and uses thereof
#174COMPOSITIONS AND METHODS FOR THE INNATE IMMUNE RESPONSE PATHWAY
#175Interleukin-1α antibodies
#176Methods for monitoring IL-18
#177Methods for determining anti-TNF therapeutic response
#178Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#179Method for diagnosing cardiovascular diseases
#180Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
#181IL-1F6 polypeptides
#182GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM CHILDREN WITH DIABETES
#183METHODS AND PRODUCTS FOR MODULATION OF REPRODUCTIVE PROCESSES AND FOR DIAGNOSIS, PROGNOSTICATION AND TREATMENT OR RELATED CONDITIONS
#184Antibody profiling for determination of patient responsiveness
#185Methods for inhibiting pain
#186Methods for producing ex vivo models for inflammatory disease and uses thereof
#187COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS
#188Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
#189Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#190Biomarkers for wound healing
#191Methods for monitoring IL-18
#192Methods for producing Ex vivo models for inflammatory disease and uses thereof
#193IL1-β: a new target for myeloma therapy
#194Methods of using GST-Omega-2
#195Compositions and methods for the treatment of depression and other affective disorders
#196Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation